Cancer prevention research (Philadelphia, Pa.)

Cancer Prev Res (Phila) · ISSN (e) 1940-6215 · 11 papers in corpus
article 2021
doi:10.1158/1940-6207.capr-21-0090 ·PMID:34244153

Abstract Menstrual pain has been associated with increased ovarian cancer risk, presumably through increased inflammation, which is known to play a critical role in ovarian carcinogenesis. Analgesic medications are frequently used to treat …

2021
doi:10.1158/1940-6207.capr-20-0174 ·PMID:32917642

Several studies have assessed the relationship between sleep duration and ovarian cancer risk, but the results are conflicting. Importantly, no studies addressed the relationship between sleep disturbance or sleep quality and ovarian cancer…

2021
doi:10.1158/1940-6207.capr-21-0121 ·PMID:34413116

Evidence suggesting that high-grade serous ovarian cancers originate in the fallopian tubes has led to the emergence of opportunistic salpingectomy (OS) as an approach to reduce ovarian-cancer risk. In the U.S., some national societies now …

2020
doi:10.1158/1940-6207.capr-19-0416 ·PMID:32051178

Prior small reports have postulated a link between gastrointestinal polyposis and childhood and young adulthood cancer (CYAC) treatment (therapy-associated polyposis; TAP), but this remains a poorly understood phenomenon. The aim of this st…

2018
doi:10.1158/1940-6207.capr-18-0009 ·PMID:30232083

The prognosis of women diagnosed with invasive high-grade serous ovarian carcinoma (HGSC) is poor. More information about serous tubal intraepithelial carcinoma (STIC) and serous tubal intraepithelial lesions (STIL), putative precursor lesi…

2015
doi:10.1158/1940-6207.capr-14-0293 ·PMID:25586903

Bilateral salpingo-oophorectomy (BSO) has become the standard-of-care for risk reduction in women at hereditary risk of ovarian cancer. Although this procedure significantly decreases both the incidence of and mortality from ovarian cancer,…

other 2014
doi:10.1158/1940-6207.CAPR-13-0367 ·PMID:24449056

The higher incidence of thyroid cancer in women compared with men suggests an influence of sex steroid hormones in the etiology of this malignancy. We investigated a comprehensive set of potential indicators of lifetime sex steroid hormone …

2014
doi:10.1158/1940-6207.capr-13-0408 ·PMID:24950779

We hypothesized that (i) preclinical biologic evidence exists for the role of androgens in ovarian cancer development and (ii) flutamide treatment of women at high risk for ovarian cancer may identify meaningful tissue biomarkers of androge…

2013
doi:10.1158/1940-6207.capr-13-0037 ·PMID:23761272

Genital powder use has been associated with risk of epithelial ovarian cancer in some, but not all, epidemiologic investigations, possibly reflecting the carcinogenic effects of talc particles found in most of these products. Whether risk i…

2012
doi:10.1158/1940-6207.capr-11-0430 ·PMID:22556202

Bilateral oophorectomy is used as a risk reduction strategy in BRCA1/2 mutation carriers, although data on long-term side effects are not yet available. In the general population, oophorectomy, particularly at a young age, has been associat…

article 2010
doi:10.1158/1940-6207.capr-10-0244 ·PMID:21119048

CDB-4124 (Proellex or telapristone acetate) is a modulator of progesterone receptor (PR) signaling, which is currently employed in preclinical studies for prevention and treatment of breast cancer and has been used in clinical studies for t…